Chrystal sells TEVA 52.8: Barclays Pharmaceuticals Analyst: Teva Must Be Aggressive With Acquisitions
The second part of his forecast â acquisitions by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)) â is likely to come to pass in the future. According to Tsao, âIn light of Tevaâs abilities, and its success in transferring patients .. ...
48 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home